36 results

• Popular Blood Pressure Drugs And Diabetes May Increase Coronavirus Risks, Some Researchers Warn

  March 17, 2020

  Irvin Jackson

  Some researcher warn that blood pressure medications like valsartan and Benicar could increase the severity and lethality of the coronavirus.

• Recalled Valsartan Pills Not Properly Preserved for Litigation, Plaintiffs Claim

  January 21, 2020

  Irvin Jackson

  Plaintiffs say defendants are destroying recalled, tainted pills which could serve as crucial evidence in valsartan recall lawsuit trials.

• Valsartan Recalls Resulted In Significant Drop In Use, As Well As Confusion and Concerns Among Doctors, Patients

  January 16, 2020

  Irvin Jackson

  A new study suggests there was confusion over which drugs to use following the initial valsartan recalls due to NDMA contamination.

• Lawsuits Over Losartan, Irbesartan Consolidated With Valsartan Recall Claims

  December 26, 2019

  Irvin Jackson

  A panel of federal judges has ordered all losartan and irbesartan recall lawsuits folded into consolidated valsartan litigation.

• Valsartan, Losartan Recall Problems Leads To FDA Warning Letter For Torrent Pharmaceuticals

  October 17, 2019

  Irvin Jackson

  The FDA has issued a warning letter to Torrent Pharmaceuticals regarding problems at a losartan manufacturing plant in India as part of its investigation into contaminated hypertension drugs.

• FDA Taking Too Long To Assess Cancer Problems with Valsartan, Other Blood Pressure Drugs: Report

  October 11, 2019

  Austin Kirk

  A new analysis warns that the FDA has only screened a quarter of all valsartan and similar high blood pressure medications for cancer-causing impurities.

• Motion Seeks To Add Irbesartan and Losartan Lawsuits to Pending Valsartan Litigation

  September 19, 2019

  Austin Kirk

  A status conference this week will discuss whether losartan and irbesartan lawsuits should be added to a valsartan recall lawsuit MDL, as all three drugs saw massive recalls over cancer-causing impurities.

• Cancer Risk from Valsartan, Losartan, Other Recalled Blood Pressure Drugs Still Being Investigated by FDA

  August 29, 2019

  Irvin Jackson

  The FDA is expanding its hunt for cancer-causing impurities in drugs beyond hypertension medications like valsartan.

• Valsartan Recalls May Have Been Caused By Indian Solvent Recovery Firm, At Least In Part: FDA

  August 16, 2019

  Irvin Jackson

  A solvent company in India received a warning letter from the FDA, indicating it may have played a role in massive generic valsartan recalls issued over cancer-causing impurities.

• Valsartan Recalls Resulted in Increase In Reports of Cancer Among Former Users: Report

  July 15, 2019

  Irvin Jackson

  A new study questions the increase in cancer-related reports linked to valsartan following a series of recalls that began last summer, saying they may have been the result of alarm among consumers and healthcare professionals.